{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:13:31Z","timestamp":1785870811344,"version":"3.56.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>To analyze the research status, hotspots, and frontiers of lean metabolic dysfunction-associated steatotic liver disease (lean MASLD) in the past 20 years using bibliometrics, providing references for further related research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Literature on lean MASLD was retrieved from the Web of Science Core Collection database. Visual analyses of publication trends, author distribution, research institutions, journal distribution, cited documents, and keywords, were performed using VOSviewer, the \u201cBibliographic\u201d package in R, and CiteSpace software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 2008 documents were included. The publication output on lean MASLD increased annually and peaked in 2023. This literature originated from 82 countries\/regions, with the United States contributing the most publications. Harvard University was the institution with the highest publication count,\n                      <jats:italic toggle=\"yes\">PLOS ONE<\/jats:italic>\n                      was the top journal in this field, and Prof Wong, Vincent Wai-Sun from The Chinese University of Hong Kong was the most productive author. The research on lean MASLD at that time primarily focused on etiology and treatment (e.g., hepatic steatosis, insulin resistance, metabolic syndrome, oxidative stress, inflammation, abdominal obesity, sarcopenia,\n                      <jats:italic toggle=\"yes\">patatin-like phospholipase domain-containing 3<\/jats:italic>\n                      gene, and gut microbiota), as well as epidemiology and diagnostic methods.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study systematically depicted the 2-decade developmental trajectory of lean MASLD using bibliometric methods for the first time, and provides academic references for clinicians and scholars to grasp the field\u2019s hotspots, frontiers, and evolutionary trends.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049183","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:01:41Z","timestamp":1780718501000},"page":"e49183","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Global research trends of lean metabolic dysfunction-associated steatotic liver disease (lean MASLD) from 2005 to 2024: Bibliometric and visualization analysis"],"prefix":"10.1097","volume":"105","author":[{"given":"Qi","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Wuxi Xinwu District Xinrui Hospital, Wuxi, Jiangsu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9350-7270","authenticated-orcid":false,"given":"Mei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Wuxi Xinwu District Geriatric Hospital, Wuxi, Jiangsu Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"He","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Wuxi Xinwu District Xinrui Hospital, Wuxi, Jiangsu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Hua","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Wuxi Xinwu District Xinrui Hospital, Wuxi, Jiangsu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260711","first-page":"101","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement.","volume":"70","author":"Eslam","year":"2021","journal-title":"Gut"},{"key":"R2-20260711","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature.","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"R3-20260711","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1139\/h06-092","article-title":"Characteristics of metabolically obese normal-weight (MONW) subjects.","volume":"32","author":"Conus","year":"2007","journal-title":"Appl Physiol Nutr Metab"},{"key":"R4-20260711","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/j.cgh.2021.02.030","article-title":"Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults.","volume":"20","author":"Liu","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R5-20260711","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1210\/clinem\/dgac321","article-title":"Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a meta-analysis and systematic review of 10 739 607 individuals.","volume":"107","author":"Chan","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-20260711","first-page":"95","article-title":"Guideline for primary care of obesity (2019).","volume":"19","year":"2020","journal-title":"Chinese J Gen Pract"},{"key":"R7-20260711","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1111\/liv.13743","article-title":"Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: genetic and metabolic risk factors in a general population.","volume":"38","author":"Petta","year":"2018","journal-title":"Liver Int"},{"key":"R8-20260711","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.numecd.2009.06.001","article-title":"Normal weight obesity: relationship with lipids, glycaemic status, liver enzymes and inflammation.","volume":"20","author":"Marques-Vidal","year":"2010","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R9-20260711","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jbusres.2022.04.042","article-title":"Guidelines for advancing theory and practice through bibliometric research.","volume":"148","author":"Mukherjee","year":"2022","journal-title":"J Bus Res"},{"key":"R10-20260711","doi-asserted-by":"crossref","first-page":"e0216135","DOI":"10.1371\/journal.pone.0216135","article-title":"Worldwide research trends on aristolochic acids (1957\u20132017): suggestions for researchers.","volume":"14","author":"Zhou","year":"2019","journal-title":"PLoS One"},{"key":"R11-20260711","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping.","volume":"84","author":"Van Eck","year":"2010","journal-title":"Scientometrics"},{"key":"R12-20260711","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/asi.20317","article-title":"CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature.","volume":"57","author":"Chen","year":"2006","journal-title":"J Am Soc Inform Sci Technol"},{"key":"R13-20260711","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/10618600.1996.10474713","article-title":"R: a language for data analysis and graphics.","volume":"5","author":"Ihaka","year":"1996","journal-title":"J Comput Graph Stat"},{"key":"R14-20260711","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.physa.2016.01.017","article-title":"Evolutionary features of academic articles co-keyword network and keywords co-occurrence network: based on two-mode affiliation network.","volume":"450","author":"Li","year":"2016","journal-title":"Physica A"},{"key":"R15-20260711","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R16-20260711","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia.","volume":"67","author":"Fan","year":"2017","journal-title":"J Hepatol"},{"key":"R17-20260711","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis.","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cell Metab"},{"key":"R18-20260711","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis.","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R19-20260711","first-page":"283","article-title":"Linking gut microbiota and inflammation to obesity and insulin resistance.","volume":"31","author":"Saad","year":"2016","journal-title":"Physiology (Bethesda)"},{"key":"R20-20260711","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R21-20260711","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/gutjnl-2015-310798","article-title":"Liver PPAR\u03b1 is crucial for whole-body fatty acid homeostasis and is protective against NAFLD.","volume":"65","author":"Montagner","year":"2016","journal-title":"Gut"},{"key":"R22-20260711","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease.","volume":"130","author":"Smith","year":"2020","journal-title":"J Clin Invest"},{"key":"R23-20260711","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1210\/jc.2015-1966","article-title":"High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels.","volume":"100","author":"Portillo-Sanchez","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R24-20260711","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jhep.2017.11.012","article-title":"Determinants of fibrosis progression and regression in NASH.","volume":"68","author":"Schuppan","year":"2018","journal-title":"J Hepatol"},{"key":"R25-20260711","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cgh.2018.05.057","article-title":"Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates.","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R26-20260711","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/ajg.2012.314","article-title":"Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults.","volume":"107","author":"Kwon","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R27-20260711","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2337\/cd18-0026","article-title":"Patients with lean nonalcoholic fatty liver disease are metabolically abnormal and have a higher risk for mortality.","volume":"37","author":"Golabi","year":"2019","journal-title":"Clin Diabetes"},{"key":"R28-20260711","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3390\/jcm7120562","article-title":"Lean patients with non-alcoholic fatty liver disease have a severe histological phenotype similar to obese patients.","volume":"7","author":"Denkmayr","year":"2018","journal-title":"J Clin Med"},{"key":"R29-20260711","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.27242","article-title":"Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis.","volume":"61","author":"Smagris","year":"2015","journal-title":"Hepatology"},{"key":"R30-20260711","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.cgh.2017.04.045","article-title":"Liver and cardiovascular damage in patients with lean nonalcoholic fatty liver disease, and association with visceral obesity.","volume":"15","author":"Fracanzani","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R31-20260711","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.30908","article-title":"Lean NAFLD: a distinct entity shaped by differential metabolic adaptation.","volume":"71","author":"Chen","year":"2020","journal-title":"Hepatology"},{"key":"R32-20260711","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.cell.2024.03.034","article-title":"Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway.","volume":"187","author":"Nie","year":"2024","journal-title":"Cell"},{"key":"R33-20260711","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","article-title":"Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.","volume":"16","author":"Shen","year":"2017","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"R34-20260711","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s12072-024-10674-6","article-title":"Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact.","volume":"18","author":"Alisi","year":"2024","journal-title":"Hepatol Int"},{"key":"R35-20260711","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jceh.2019.01.007","article-title":"Magnitude of nonalcoholic fatty liver disease: eastern perspective.","volume":"9","author":"Ching-Yeung","year":"2019","journal-title":"J Clin Exp Hepatol"},{"key":"R36-20260711","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/ijo.2009.130","article-title":"Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study.","volume":"33","author":"Kim","year":"2009","journal-title":"Int J Obes (Lond)"},{"key":"R37-20260711","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1152\/japplphysiol.01026.2004","article-title":"IL-6-induced skeletal muscle atrophy.","volume":"98","author":"Haddad","year":"2005","journal-title":"J Appl Physiol"},{"key":"R38-20260711","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.cgh.2017.04.040","article-title":"Histologic scores for fat and fibrosis associate with development of type 2 diabetes in patients with nonalcoholic fatty liver disease.","volume":"15","author":"Bj\u00f6rkstr\u00f6m","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R39-20260711","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1530\/EJE-14-0112","article-title":"External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals.","volume":"171","author":"Cuthbertson","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"R40-20260711","doi-asserted-by":"crossref","first-page":"486","DOI":"10.5009\/gnl19173","article-title":"Simple noninvasive scores are clinically useful to exclude, not predict, advanced fibrosis: a study in Turkish patients with biopsy-proven nonalcoholic fatty liver disease.","volume":"14","author":"Kaya","year":"2020","journal-title":"Gut Liver"},{"key":"R41-20260711","doi-asserted-by":"crossref","first-page":"e00042","DOI":"10.14309\/ctg.0000000000000042","article-title":"Role of fatty liver index and metabolic factors in the prediction of nonalcoholic fatty liver disease in a lean population receiving health checkup.","volume":"10","author":"Hsu","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"R42-20260711","doi-asserted-by":"crossref","first-page":"346","DOI":"10.51821\/85.2.9775","article-title":"Non-invasive screening, staging and management of metabolic dysfunction-associated fatty liver disease (MAFLD) in type 2 diabetes mellitus patients: what do we know so far?","volume":"85","author":"Binet","year":"2022","journal-title":"Acta Gastroenterol Belg"},{"key":"R43-20260711","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/j.gastro.2022.06.023","article-title":"AGA clinical practice update: diagnosis and management of nonalcoholic fatty liver disease in lean individuals: expert review.","volume":"163","author":"Long","year":"2022","journal-title":"Gastroenterology"},{"key":"R44-20260711","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/apt.14112","article-title":"Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients.","volume":"46","author":"Sookoian","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"R45-20260711","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s12072-025-10801-x","article-title":"Global prevalence, metabolic characteristics, and outcomes of lean-MAFLD: a systematic review and meta-analysis.","volume":"19","author":"Cheah","year":"2025","journal-title":"Hepatol Int"},{"key":"R46-20260711","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.cgh.2021.07.016","article-title":"Natural history of nonalcoholic fatty liver disease with normal body mass index: a population-based study.","volume":"20","author":"Ahmed","year":"2022","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049183","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:02:05Z","timestamp":1783778525000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":46,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049183","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"2025-07-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}